FEBS Letters · 2001 · 69 citations · 38 references
Life SciencesCardiologyImmunologyCell SignalingInflammationSignal TransductionCytokine BiologyCytokine-mediated PathologyInflammatory Cell SignalingInflammatory MediatorsInflammatory PathologyInflammatory SignalingAdenoviral VectorsAntibodiesInflammation In Cardiovascular DiseaseInflammatory ActivationInflammatory Cytokine EffectsNuclear Factor Kappa B ModulationNuclear Factor Kappa B SignalingVascular Smooth Muscle Regulation
Migration of vascular smooth muscle cells (VSMC) is a crucial event in the formation of vascular stenotic lesions. Tumor necrosis factor-alpha (TNF-alpha) is elaborated by VSMC in atherosclerosis and following angioplasty. We investigated the role of nuclear factor-kappaB (NF-kappaB) in human VSMC migration induced by TNF-alpha. Adenoviral expression of a mutant form of the inhibitor of NF-kappaB, IkappaB-alphaM, suppressed TNF-alpha-triggered degradation of cellular IkappaB-alpha, inhibited activation of NF-kappaB, and attenuated TNF-alpha-induced migration. Further, IkappaB-alphaM suppressed TNF-alpha-stimulated release of interleukin-6 and -8 (IL-6 and IL-8). Neutralization of IL-6 and IL-8 with appropriate antibodies reduced TNF-alpha-induced VSMC migration. Addition of recombinant IL-6 and IL-8 stimulated migration. Collectively, our data provide initial evidence that TNF-alpha-mediated VSMC migration requires NF-kappaB activation and is associated with induction of IL-6 and IL-8 which act in an autocrine manner.
38
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Julia A. Romashkova, Sergei S. Makarov · Nature · 1999 · 1.8K citations
E. Britta-Mareen Traenckner, Heike L. Pahl, Timothy P. Henkel et al. · The EMBO Journal · 1995 · 1K citations · Full text